A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth von Colin, S, Guilmain, W, Creoff, E, Schneider, C, Steverlynck, C, Bongaerts, M, Legrand, E, Vannier, J P, Muraine, M, Vasse, M, Al-Mahmood, S

Volltext

410P GNT0004, Genethon's AAV8 vector-delivered microdystrophin gene therapy of Duchenne muscular dystrophy, first data of the phase I/II part of the GNT-016-MDYF all-in-one clinica... von Laugel, V., De Lucia, S., Davion, J., Daniele, N., Cao, F., Sanz, M., Buscara, L., Blaie, S., Thibaut, L., Sagot, M., Riviere, A., Creoff, E., Lelait, M., Valent, A., Perret, G., Braun, S., Muntoni, F.

Volltext

A truncated form of CD9-partner I (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth von COLIN, S, GUILMAIN, W, AL-MAHMOOD, S, CREOFF, E, SCHNEIDER, C, STEVERLYNCK, C, BONGAERTS, M, LEGRAND, E, VANNIER, J. P, MURAINE, M, VASSE, M

Volltext

EP-1422: Efficacy and toxicity outcome of Stereotactic Body Radiation Therapy for hepatocellular carcinoma von Creoff, M., Castan, F., Molinier, J., Assenat, E., Ychou, M., Lauche, O., Llacer, C., Aillerès, N., Fenoglietto, P., Azria, D., Riou, O.

Volltext

Two recent developments in XMCD von Baudelet, F., Dubuisson, J. M., Hébert, C., Créoff, C., Pointal, L., Andouard, R., Odin, S., Dartyge, E., Krill, G., Giorgetti, C., Chervin, J. C., Itié, J. P., Polian, A., Fontaine, A., Pizzini, S., Kappler, J. P.

Volltext